To ensure that Pediatric Chemotherapy/Biotherapy Providers stay current in their knowledge of safe chemotherapy and biotherapy administration, APHON requires active Providers to renew their status.
The first renewal will occur within two years of attending a pediatric chemotherapy/biotherapy provider course and achieving a passing score on the post-test and will then occur every three years after that. This is an essential part of the Pediatric Chemotherapy/Biotherapy Provider Program, which allows all Providers to keep pace with the ever-changing advancement in medicine and technology.
This online program asks participants to read updated administration material, take a post-test, and complete an evaluation. Upon successful completion, participants will be awarded two continuing nursing education (CNE) contact hours.
Content of the Program
- Prognostic Indicators
- Pulmonary Complications
- Safe Handling of Hazardous Drugs
- Biotherapy Principles
- CAR-T Cell Therapy
The renewal exam consists of 25 questions, and you must achieve a minimum score of 80% to pass. If you are unsuccessful in your first attempt, you will be permitted to retake the exam one time at no additional cost. If you do not achieve a passing score after two attempts, you will be required to retake the 2-day provider course.
As a result of participating in this educational activity, the learner will gain specific knowledge, according to national standards, that is needed to safely and consistently administer chemotherapy and biotherapy to children and adolescents. Post-testing and evaluations will evidence the measurement of this outcome.
The dates for provider renewals are as follows (please refer to your provider card for the issue date):
Provider Card Issue Date
Renewal Fee Structure
The renewal for providers that expired on December 31, 2019 is now closed. Providers that failed to access and complete the provider renewal by December 31, 2019 will be required to sit for a 2-day provider course to reinstate their provider status. No refunds will be issued for anyone that purchased the provider renewal but did not complete the exam.
Provider Renewal Policies
Current Pediatric Chemotherapy/Biotherapy providers that expire December 31, 2020, will be able to renew their provider status from October 1– December 31, 2020. The provider renewal program will close at 11 pm Central Time on December 31, 2020.
You can log in and out of the system as many times as you’d like to read the downloadable renewal packet PDF until December 31, 2020 (11 pm CST). When you are ready, log into the exam to begin the 90-minute timer and complete the 25-question open book exam. Should you run out of time, the exam will tabulate your score as it stands at the end of the 90 minutes. You must achieve a minimum score of 80% to pass. You will be allowed to retake the post-test one additional time if you fail the first attempt at no additional fee. If you fail both attempts, you will be required to retake the 2-day provider course.
The exam must be completed by 11 pm Central Time on December 31, 2020.
Note: Staff support will not be available to provide assistance with technical issues on weekend days. We strongly encourage all providers to initiate the renewal process during normal business hours when staff will be available to provide support.
You will not be permitted to take the exam after 11 pm Central Time, December 31, 2020, regardless if payment was submitted nor will a refund be given. Additionally, no refunds will be given for failure to complete the exam by December 31, 2020, or failure to achieve a passing score on the exam.
Providers that previously completed the renewal process may access their CNE certificate by logging into their APHON website account. Users will be required to log in using their APHON website ID and password.
All orders are final once payment is submitted. APHON reserves the right to refuse to refund duplicate payments submitted for the provider renewal exam. We strongly encourage providers to verify previous payment submission before completing the renewal exam purchase.
Accreditation and Disclaimer
This program may also be recognized for the amount of 1.2 hours of pharmacology content indicated as calculated by the APHON Pediatric Chemotherapy/Biotherapy Provider Program Committee. APHON does not award pharmacology credit. APHON recommends that attendees retain a copy of the certificate for supportive documentation to submit to your state’s nursing board. Please note that you may not apply CNE toward pharmacology content. The content may be used in only one area, nursing contact hours, or pharmacology content.
Official ONCC Statement and Disclaimer
The program content has been reviewed by the Oncology Nursing Certification Corporation (ONCC) and is acceptable for recertification points in the following areas: Diagnosis and Staging, Disease-Related Biology, Health Promotion/Screening, and Early Detection, Oncologic Emergencies, Professional Practice, Scientific Basis for Practice, Survivorship, Symptom Management, and Treatment.
Disclaimer: ONCC review is only for designating content to be used for recertification points and is not for CNE accreditation. CNE programs must be formally approved for contact hours by an acceptable accreditor/approver of nursing CE to be used for recertification by ONCC. If the CNE provider fails to obtain formal approval to award contact hours by an acceptable accrediting/approval body, no information related to ONCC recertification may be used in relation to the program.
Course content applies to multiple content areas across multiple credentials. Individual nurse’s learning plans are linked to the ONCC Test Blueprint for the certification they hold. Review the current test blueprint available on the ONCC website to determine where the content fits.
The Association of Pediatric Hematology/Oncology Nurses (APHON) is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.
A staff member, volunteer, or family member who has an affiliation with a commercial company must declare that relationship in advance of involvement with an educational activity that could be used as a forum to promote the interest of that company and its products. There are no disclosures to report for this activity.